Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunctionYingzhi Bi, John E. Macor, Andrew J. Watson et al.|Bioorganic & Medicinal Chemistry Letters|2004Cited by 49
Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1<i>H</i>)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119Dean A. Wacker, Jeffrey A. Robl, Ying Wang et al.|Journal of Medicinal Chemistry|2014Cited by 46
Substituted Pyrazolopyridopyridazines as Orally Bioavailable Potent and Selective PDE5 Inhibitors: Potential Agents for Treatment of Erectile DysfunctionGuixue Yu, John E. Macor, Helen J. Mason et al.|Journal of Medicinal Chemistry|2003Cited by 38
The discovery of novel, potent and selective PDE5 inhibitorsYingzhi Bi, John E. Macor, Patrick Stoy et al.|Bioorganic & Medicinal Chemistry Letters|2001Cited by 30